About iRhythm Technologies, Inc. 
iRhythm Technologies, Inc.
Pharmaceuticals & Biotechnology
iRhythm Technologies, Inc. is a digital health company. The Company develops and commercializes solutions that integrate biosensor technology, patient data, analytics and medical expertise. The Company offers flagship solution, the ZIO Service. Its myZIO provides a way for patients to enter their symptoms as they occur and on-the-go while wearing the ZIO Patch. Its ZIO Event Card is indicated for use on patients who experience transient symptoms, such as syncope, palpitations, and shortness of breath or dizziness. Its ZIO XT Patch is a non-invasive, water-resistant heart monitor, which prompts high patient compliance and a higher diagnostic yield. Its ZIO Report produces a higher diagnostic yield and to change patient management. The Company’s Zio service combines a wire-free, patch-based, wearable biosensor with a proprietary cloud-based data analytic platform to help physicians monitor patients and diagnose arrhythmias.
Company Coordinates 
Company Details
650 Townsend St Ste 500 , SAN FRANCISCO CA : 94103-6227
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 80 Schemes (49.47%)
Foreign Institutions
Held by 139 Foreign Institutions (23.64%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Abhijit Talwalkar
Independent Chairman of the Board
Mr. Bruce Bodaken
Independent Director
Ms. Renee Budig
Independent Director
Dr. Cathleen Noel Merz
Independent Director
Mr. Mark Rubash
Independent Director
Mr. Raymond Scott
Independent Director
Revenue and Profits:
Net Sales:
187 Million
(Quarterly Results - Jun 2025)
Net Profit:
-14 Million
Pharmaceuticals & Biotechnology
USD 6,010 Million (Small Cap)
NA (Loss Making)
NA
0.00%
1.15
-51.95%
57.98






